Transmissible spongiform encephalopathies (TSEs) are a group of invariably fatal neurodegenerative disorders. The causal agent is an aberrantly folded isoform (PrPSc or prion) of the endogenous prion protein (PrPC) which is neurotoxic and amyloidogenic and induces misfolding of its physiological counterpart. The intrinsic physical characteristics of these infectious proteinaceous pathogens makes them highly resistant to the vast majority of physicochemical decontamination procedures used typically for standard disinfection. This means prions are highly persistent in contaminated tissues, the environment (surfaces) and, of great concern, on medical and surgical instruments. Traditionally, decontamination procedures for prions are tested on n...
The resolution of the three-dimensional structure of infectious prions at the atomic level is pivota...
The resolution of the three-dimensional structure of infectious prions at the atomic level is pivota...
The physicochemical nature of the infectious agent in prion diseases creates a significant challenge...
The development of disinfectants with broad-range efficacy against bacteria, viruses, fungi, protozo...
Human prion disease is associated with the accumulation in brain of an abnormal glycoprotein known a...
Background: pathogenic prions (PrPSc) are amyloid-rich hydrophobic proteins which bind avidly to sur...
International audienceTo date, approximately 500 iatrogenic Creutzfeldt-Jakob disease cases have bee...
This article describes the various available in vitro systems used to study transmissible spongiform...
The misfolding of the cellular prion protein (PrPC) into the disease-associated isoform (PrPSc) and ...
Prions—infectious agents involved in transmissible spongiform encephalopathies—normally survive prot...
International audiencePrions are pathogenic infectious agents responsible for fatal, incurable neuro...
The prevalence of variant Creutzfeldt-Jakob disease (vCJD) in the population remains uncertain, alth...
International audienceThe prevalence of variant Creutzfeldt-Jakob disease (vCJD) in the population r...
Transmissible spongiform encephalopathies (TSEs) are lethal infectious neurodegenerative diseases. T...
The resolution of the three-dimensional structure of infectious prions at the atomic level is pivota...
The resolution of the three-dimensional structure of infectious prions at the atomic level is pivota...
The resolution of the three-dimensional structure of infectious prions at the atomic level is pivota...
The physicochemical nature of the infectious agent in prion diseases creates a significant challenge...
The development of disinfectants with broad-range efficacy against bacteria, viruses, fungi, protozo...
Human prion disease is associated with the accumulation in brain of an abnormal glycoprotein known a...
Background: pathogenic prions (PrPSc) are amyloid-rich hydrophobic proteins which bind avidly to sur...
International audienceTo date, approximately 500 iatrogenic Creutzfeldt-Jakob disease cases have bee...
This article describes the various available in vitro systems used to study transmissible spongiform...
The misfolding of the cellular prion protein (PrPC) into the disease-associated isoform (PrPSc) and ...
Prions—infectious agents involved in transmissible spongiform encephalopathies—normally survive prot...
International audiencePrions are pathogenic infectious agents responsible for fatal, incurable neuro...
The prevalence of variant Creutzfeldt-Jakob disease (vCJD) in the population remains uncertain, alth...
International audienceThe prevalence of variant Creutzfeldt-Jakob disease (vCJD) in the population r...
Transmissible spongiform encephalopathies (TSEs) are lethal infectious neurodegenerative diseases. T...
The resolution of the three-dimensional structure of infectious prions at the atomic level is pivota...
The resolution of the three-dimensional structure of infectious prions at the atomic level is pivota...
The resolution of the three-dimensional structure of infectious prions at the atomic level is pivota...
The physicochemical nature of the infectious agent in prion diseases creates a significant challenge...